Hakan GÖÇER, Mohammad ABUSKR, İstemihan TENGİZ, Ertuğrul ERCAN

Mitral balloon valvuloplasty followed by closure of the left atrial appendix in presence of thrombi and recurrent stroke

Hemodynamic consequences of mitral stenosis as well as inflammatory and structural changes in the left atrium increase the risk of developing atrial fibrillation and predispose to thrombus formation, primarily in the left atrial appendage. Percutaneous mitral balloon valvuloplasty for hemodynamically severe rheumatic mitral stenosis with favorable valve anatomy reduces the risk of thromboembolic events and stroke. Although the presence of left atrial thrombus is determined as a contraindication, percutaneous intervention has been found to be safe when the thrombus is localized to the atrial appendix. Left atrial appendix occlusion is an alternative treatment of choice for stroke prevention in patients with high stroke risk in whom oral anticoagulation is contraindicated or in patients with thromboembolic events in spite of adequate anticoagulation. Here we report a case of a 91-year-old-woman with very severe mitral stenosis and chronic atrial fibrillation, with a left atrial appendix thrombus and a history of recurrent stroke despite warfarin. Balloon valvuloplasty was performed firstly without encountering any embolic events. The thrombus was dissolved following restored of the left atrial flow. Subsequently, atrial appendix occlusion device was implanted in order to reduce the risk of recurrent thromboembolic events.

PDF

___

1. Horstkotte D, Niehues R, Strauer B.E., Pathomorphological aspects, etiology and natural history of acquired mitral valve stenosis. Eur Heart J. 1991;12:55- 60.

2. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523.

3. Inoue K, Owaki T, Nakamura T, et al. Clinical application of Transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984;87:394-402.

4. Chiang CW, Lo SK, Ko YS. Predictors of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med. 1998;128:885-9.

5. Baumgartner H, Falk V, Bax JJ, et al. ESC Scientific Document Group; 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38: 2739-2791.

6. Algul F.E, Kaplan Y. Ischemic stroke in young adults: Gender-based differences. Med-Science. 2020;9:132-5.